Published 1 December 2008, doi:10.1136/bmj.a2800
Cite this as: BMJ 2008;337:a2800

News

Charity commits more money to investigating cancers with poor survival

Susan Mayor

1 London

The first 150 words of the full text of this article appear below.

Cancer Research UK, a major independent funder of research into cancer, will focus on cancers that have poor survival rates, including pancreatic, oesophageal, and lung cancers, it says in its five year plan published today. It will also increase investment in research into radiotherapy and surgical techniques.

The plan sets out the details of how the organisation will spend its budget of around £300m ({euro}360m; $460m) a year to reduce cancer mortality. Although the charity will remain the United Kingdom’s largest funder of research into a range of cancers, it will introduce major initiatives in research into pancreatic and oesophageal cancers and increase funding for research into lung cancer, with special funding streams for work in these areas.

Harpal Kumar, the charity’s chief executive, said, "In these three cancers there has been a degree of nihilism and even a defeatist attitude around the world, which has led to limited . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Doc2Doc Vacancy
Access jobs at BMJ Careers
Whats new online at Student BMJ